BG91270A - Антивирусно и антибактериално средство и метод за използването му - Google Patents

Антивирусно и антибактериално средство и метод за използването му

Info

Publication number
BG91270A
BG91270A BG091270A BG9127090A BG91270A BG 91270 A BG91270 A BG 91270A BG 091270 A BG091270 A BG 091270A BG 9127090 A BG9127090 A BG 9127090A BG 91270 A BG91270 A BG 91270A
Authority
BG
Bulgaria
Prior art keywords
antiviral
antibacterial agent
enzymes
forms
dimeric forms
Prior art date
Application number
BG091270A
Other languages
English (en)
Other versions
BG60544B1 (en
Inventor
Witold Kiczka
Original Assignee
Nika Health Products Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Limited filed Critical Nika Health Products Limited
Publication of BG91270A publication Critical patent/BG91270A/bg
Publication of BG60544B1 publication Critical patent/BG60544B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретението се отнася до състави с антивирусен и антибактериален ефект, които съдържат димерните форми на ензими, като лизозим и рибонуклеаза и фармацевтично приемлив носител. Димерните форми са по-ефективни при лечение на различни заболявания, тъй като са по-малко цитотоксични в сравнение с мономерните форми на ензимите. 32 претенции
BG91270A 1988-05-26 1990-02-22 Antiviral and antibacterial preparation and method for its usage BG60544B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (2)

Publication Number Publication Date
BG91270A true BG91270A (bg) 1993-12-24
BG60544B1 BG60544B1 (en) 1995-08-28

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
BG91270A BG60544B1 (en) 1988-05-26 1990-02-22 Antiviral and antibacterial preparation and method for its usage

Country Status (23)

Country Link
US (3) US5200182A (bg)
EP (1) EP0380484B1 (bg)
JP (1) JPH0649659B2 (bg)
AT (1) ATE93143T1 (bg)
AU (1) AU624331B2 (bg)
BG (1) BG60544B1 (bg)
CA (1) CA1335425C (bg)
CS (1) CS277030B6 (bg)
DK (1) DK173078B1 (bg)
ES (1) ES2011577A6 (bg)
FI (1) FI900412A7 (bg)
HK (1) HK42394A (bg)
HU (1) HU204710B (bg)
IL (1) IL90092A (bg)
LV (1) LV10054B (bg)
MA (1) MA21560A1 (bg)
MW (1) MW390A1 (bg)
OA (1) OA09785A (bg)
PH (1) PH26284A (bg)
RU (1) RU2092183C1 (bg)
WO (1) WO1989011294A1 (bg)
YU (1) YU109289A (bg)
ZA (1) ZA893382B (bg)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
AU645252B2 (en) * 1990-01-08 1994-01-13 Nika Health Products Ltd. Method of producing ribonuclease dimers
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
RU2157206C1 (ru) * 1999-03-10 2000-10-10 Оренбургская государственная медицинская академия Бактерицидный отогель
RU2172179C2 (ru) * 1999-06-24 2001-08-20 Сельков Сергей Алексеевич Шарики "биосан" для лечения кольпитов различного генеза и способ лечения кольпитов различного генеза
RU2191576C2 (ru) * 1999-07-27 2002-10-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения субклинической формы генитальной герпесвирусной инфекции у женщин
RU2200550C2 (ru) * 1999-10-29 2003-03-20 Научно-исследовательская лаборатория иммунохимиотерапии лепры и иммунотропных средств с клиникой и опытно-экспериментальным производством Новые лекарственные формы димоцифона в терапии лепры, зудящих и аллергодерматозов, герпетиформного дерматита дюринга
RU2163119C1 (ru) * 2000-04-26 2001-02-20 Свистов Виталий Владимирович Антисептическое средство
RU2180593C1 (ru) * 2000-11-08 2002-03-20 Айламазян Эдуард Карпович Фармацевтическая композиция для лечения и профилактики генитального герпеса, хронической папилломы вирусной инфекции и профилактики рака шейки матки (варианты)
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
RU2177781C1 (ru) * 2000-12-06 2002-01-10 Научный Центр Здоровья детей РАМН Суппозитории ректальные, содержащие витаминный комплекс
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
RU2195927C1 (ru) * 2001-07-13 2003-01-10 ООО "Тенториум" Абиес-свеча "канделла-два"
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
WO2005115477A2 (en) 2004-04-13 2005-12-08 Quintessence Biosciences, Inc. Non-natural ribonuclease conjugates as cytotoxic agents
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
EP2044097A4 (en) * 2006-06-23 2010-10-06 Quintessence Biosciences Inc Modified ribonucleases
US8298801B2 (en) 2006-07-17 2012-10-30 Quintessence Biosciences, Inc. Methods and compositions for the treatment of cancer
RU2009136424A (ru) * 2007-03-02 2011-04-10 СЕНТ СИМЕОН ЭлДиЭй (US) Композиция и способ лечения папилломавируса и саркоидов лошадей
WO2009036000A2 (en) * 2007-09-11 2009-03-19 University Of Maryland, Baltimore Methods of treating a microbial infection by modulating rnase-l expression and/or activity
EP2205271B1 (en) * 2007-10-08 2014-05-21 Quintessence Biosciences, Inc. Compositions and methods for ribonuclease-based therapies
US8029782B2 (en) 2008-10-01 2011-10-04 Quintessence Biosciences, Inc. Therapeutic ribonucleases
WO2010099182A1 (en) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Activated creatinine and precursors as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
KR20150027152A (ko) 2012-05-29 2015-03-11 다누타 크루셰프스카 인간 및 동물 모두에서 예방 및 의약에 유용한 락토바실러스 류테리 ｄａｎ080을 포함하는 나노프로덕트 및 이의 의학적 용도
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2014152678A1 (en) 2013-03-15 2014-09-25 University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
CN106029089B (zh) * 2014-02-21 2020-12-29 丘比株式会社 诺如病毒灭活剂及其制造方法
WO2016017784A1 (ja) * 2014-07-31 2016-02-04 キユーピー株式会社 含水流動状組成物及びその製造方法、並びに、リゾチーム加工品及び／又はその塩並びにその製造方法
IL315468A (en) 2014-09-17 2024-11-01 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
WO2018123821A1 (ja) 2016-12-28 2018-07-05 Dic株式会社 分散体及びそれを用いたインクジェット用インク組成物、光変換層、及び液晶表示素子
AU2018337974B2 (en) 2017-09-20 2024-06-27 Spogen Biotech Inc. Fusion proteins, recombinant bacteria, and exosporium fragments for plant health
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (bg) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug

Also Published As

Publication number Publication date
HUT54060A (en) 1991-01-28
HU204710B (en) 1992-02-28
ES2011577A6 (es) 1990-01-16
CS277030B6 (en) 1992-11-18
CS318089A3 (en) 1992-05-13
WO1989011294A1 (en) 1989-11-30
YU109289A (en) 1991-08-31
PH26284A (en) 1992-04-10
DK16890A (da) 1990-01-22
ZA893382B (en) 1991-01-30
DK16890D0 (da) 1990-01-22
RU2092183C1 (ru) 1997-10-10
OA09785A (en) 1994-04-15
FI900412A0 (fi) 1990-01-25
FI900412A7 (fi) 1990-01-25
US6099835A (en) 2000-08-08
CA1335425C (en) 1995-05-02
EP0380484B1 (en) 1993-08-18
ATE93143T1 (de) 1993-09-15
MW390A1 (en) 1990-11-14
US5200182A (en) 1993-04-06
HU883981D0 (en) 1990-12-28
HK42394A (en) 1994-05-13
DK173078B1 (da) 1999-12-20
US5466449A (en) 1995-11-14
LV10054B (en) 1995-02-20
BG60544B1 (en) 1995-08-28
AU624331B2 (en) 1992-06-11
JPH0649659B2 (ja) 1994-06-29
LV10054A (lv) 1994-05-10
EP0380484A1 (en) 1990-08-08
MA21560A1 (fr) 1989-12-31
JPH03504121A (ja) 1991-09-12
IL90092A (en) 1995-03-30
AU1940888A (en) 1989-12-12

Similar Documents

Publication Publication Date Title
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
EP0154344A3 (en) Antiviral pharmaceutical preparations and methods for their use
MX9702932A (es) L-ribofuranosilnucleosidos.
FI895064A7 (fi) Syklosporiinia sisältäviä koostumuksia silmätulehdusten hoitoon
FI914919A7 (fi) AIDS-potilaiden neurologisten sairauksien hoidossa tehokkaat farmaseuttiset koostumukset, jotka sisältävät vaikuttavana aineena vähintään yhtä yhdistettä, joka on valittu ryhmästä, joka käsittää S-adenosyyli -L-metioniinisuolan, 5-metyylitetrahydrofool
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
EP1157698A3 (en) Treatment of inflammatory diseases with oxypurine nucleosides
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
IL91184A0 (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
ATE81467T1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
ZA929947B (en) Method of imparting antimicrobial activity to an opthalmic composition.
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
FR2707638B1 (fr) Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
DE69709891D1 (de) Chitosan enthaltende zusammensetzung
MY106984A (en) Antiviral or antibacterial composition and method of use.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof